Cancer Drugs Market
About Cancer Drugs Market
The cancer drugs market is one of the largest and fastest-growing areas of the pharmaceutical industry. New targeted therapies, immunotherapies and cell therapies bring hope but also high costs that challenge patients and health systems.
The Cancer Drugs Market session at Cancer Research 2027 covers the business, economics and access side of cancer medicines. It links closely with treatments of cancer, which covers how these drugs are used in practice.
Spending on cancer medicines has grown rapidly as new targeted therapies and immunotherapies reach the market. These drugs can bring real benefits but often come at a high cost. Health systems must decide which treatments to fund and how to pay for them. Access varies widely between countries and regions.
Key Topics in Cancer Drugs Market
• Oncology drug pipelines and trends
• Pricing and reimbursement
• Biosimilars and generics
• Access to cancer medicines in Asia
• Health technology assessment
• Market approval and regulatory pathways
• Cost-effectiveness of cancer drugs
• Value-based pricing models
• Drug shortages and supply chains
• Industry partnerships and licensing
Recent Advances in Cancer Drugs Market
Biosimilars are lowering the cost of some important cancer drugs and widening access. New payment models, such as paying based on outcomes, are being tested for expensive treatments including cell therapies from advances in cancer research and treatment.
Targeted drugs in precision oncology are driving market growth, and many new drugs are being developed in Asia. Fair access is a key concern discussed in ethical considerations in cancer research and clinical trials.
Biosimilars and generics are helping lower prices for some important treatments. New pricing models are being tested, such as paying only when a treatment works. Asia is becoming a major centre for cancer drug development and manufacturing. Researchers are studying how to balance innovation with fair and affordable access.
Who Should Attend the Cancer Drugs Market Session
• Pharma and biotech business leaders
• Market access and pricing professionals
• Health economists
• Policy makers and payers
• Oncology pharmacists
• Investors and business development teams
Why Present Your Research in Cancer Drugs Market
Presenting at Cancer Research 2027 puts your market and access research in front of clinicians, industry and policy makers. You can connect with colleagues in clinical research and clinical trials of cancer who generate the evidence behind approvals. Industry, clinicians and policy makers rarely meet in one place. This session gives you a chance to share insights across these groups.
Frequently Asked Questions
Can industry professionals present market analyses?
Yes. Market and access analyses with clear methods are welcome.
Does this session cover biosimilars?
Yes. Biosimilars and generics are key topics.
When is Cancer Research 2027?
Cancer Research 2027 runs from 8 to 10 March 2027 at Village Hotel Changi, Singapore, and online.